(Q38401669)

2 September 2017

Comorbid substance abuse and neurocognitive function in recent-onset schizophrenia (English)

1 reference

2 September 2017

1 reference

1 reference

Peter Falkai

5

0 references

author name string

Thomas Wobrock

1

1 reference

2 September 2017

Helmut Sittinger

2

1 reference

2 September 2017

Bernd Behrendt

3

1 reference

2 September 2017

Roberto D'Amelio

4

1 reference

2 September 2017

Dieter Caspari

6

1 reference

2 September 2017

25 November 2006

1 reference

European Archives of Psychiatry and Clinical Neuroscience

2 September 2017

1 reference

2 September 2017

257

1 reference

2 September 2017

4

1 reference

2 September 2017

203-210

1 reference

https://scigraph.springernature.com/pub.10.1007/s00406-006-0707-x

2 September 2017

0 references

cites work

Prevalence of substance abuse in schizophrenia: demographic and clinical correlates.

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Substance use disorder and the early course of illness in schizophrenia and affective psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Psychosocial approaches to dual diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Schizophrenia, alcohol abuse, and violent behavior: a 26-year followup study of an unselected birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Neurocognitive and psychopathological correlates of self-monitoring ability in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Clinical effects of recent cocaine use on patients with acute schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Neuroleptics: effects on neuropsychological function in chronic schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

What are the functional consequences of neurocognitive deficits in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00406-006-0707-X

Correlates of patterns of substance abuse among patients with schizophrenia.

21 January 2018

1 reference

12 December 2020

Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function.

1 reference

12 December 2020

Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

1 reference

12 December 2020

Comorbid non-alcohol substance misuse among people with schizophrenia: epidemiological study in central London

1 reference

12 December 2020

Reliability and validity of the German version of the European Addiction Severity Index (EuropASI).

1 reference

12 December 2020

Drug and alcohol problems amongst individuals with severe mental health problems in an inner city area of the UK.

1 reference

12 December 2020

Studies of individuals with schizophrenia never treated with antipsychotic medications: a review

1 reference

12 December 2020

Substance abuse and the onset of schizophrenia.

1 reference

12 December 2020

Substance use and cognition in early psychosis

1 reference

12 December 2020

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

12 December 2020

Significance of cocaine history in schizophrenia

1 reference

12 December 2020

How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?

1 reference

12 December 2020

Prevalence of substance misuse in first-episode psychosis

1 reference

12 December 2020

CANTAB explicit memory is less impaired in addicted schizophrenia patients.

1 reference

12 December 2020

Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders

1 reference

12 December 2020

Revising axis V for DSM-IV: a review of measures of social functioning

1 reference

12 December 2020

Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics.

1 reference

12 December 2020

Medication adherence of individuals with a first episode of psychosis

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Dual diagnosis: a review of etiological theories

1 reference

12 December 2020

The effects of cognitive impairment and substance abuse on psychiatric hospitalizations

1 reference

12 December 2020

Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status

1 reference

12 December 2020

Cannabis use and age at onset of schizophrenia

1 reference

12 December 2020

Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

1 reference

12 December 2020

Effect of substance misuse in early psychosis.

1 reference

12 December 2020

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

12 December 2020

Substance use: a powerful predictor of relapse in schizophrenia

1 reference

12 December 2020

The Corsi block-tapping task: methodological and theoretical considerations.

1 reference

12 December 2020

The residual neuropsychological effects of cannabis: the current status of research.

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes

1 reference

12 December 2020

Cannabis and schizophrenia: results of a follow-up study.

1 reference

12 December 2020

Neuropsychological performance of recently abstinent alcoholics and cocaine abusers

1 reference

12 December 2020

Prevalence of alcohol and drug abuse in schizophrenic inpatients

1 reference

12 December 2020

Neuropsychological impairment in chronic cocaine abusers

1 reference

12 December 2020

Influence of cannabis abuse on schizophrenic psychopathology

1 reference

12 December 2020

Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia

1 reference

12 December 2020

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

1 reference

12 December 2020

Tardive dyskinesia in psychiatric patients with substance use disorders.

1 reference

12 December 2020

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

12 December 2020

Neuropsychological functioning in detoxified alcoholics between 18 and 35 years of age

1 reference

12 December 2020

Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse.

1 reference

12 December 2020

Etiopathogenetic mechanisms in long-term course of schizophrenia

1 reference

12 December 2020

Neurocognitive functioning and quality of life among dually diagnosed and non-substance abusing schizophrenia inpatients.

1 reference

12 December 2020

Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

1 reference

12 December 2020

Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences?

1 reference

12 December 2020

Neurocognition, symptomatology, and functional skills in older alcohol-abusing schizophrenia patients

1 reference

12 December 2020

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

1 reference

12 December 2020

Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients

1 reference

12 December 2020

Neurocognitive dysfunction in patients diagnosed with schizophrenia and alcoholism

1 reference

12 December 2020

Substance misuse, psychiatric disorder and violent and disturbed behaviour

1 reference

12 December 2020

The relation of the trail making test to organic brain damage.

1 reference

12 December 2020

Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature

1 reference

12 December 2020

Substance abuse and cognitive functioning in schizophrenia.

1 reference

12 December 2020

10.1007/S00406-006-0707-X

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference